Aldeyra Therapeutics (ALDX) Tops Q1 EPS by 6c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.32), $0.06 better than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Jefferies Downgrades United Spirits Ltd. (UNITDSPR:IN) to Hold
• Equinor ASA (ADR) (EQNR) PT Lowered to $37 at TD Cowen